- Zacks
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- Investor's Business Daily
How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin
Small biotech company Halozyme is behind some of the biggest names in medicine, including Johnson & Johnson's Darzalex and Roche's Tecentriq.
- InvestorPlace
3 Breakout Biotech Stocks on Track to Double by 2032
With the technology sector taking over in 2024, now is a great time to consider the best breakout biotech stocks to buy. Investing in these companies can be risky yet extremely rewarding, with careful selection of industry leaders. Investors often seek outsized returns in the biotechnology sector through small-cap, early-stage companies. However, many mid and large-cap biotech companies have incredible pipelines, impressive financial performance, and long-term growth opportunities. When looking
